Moreover, blockade of HIF-1α enhanced the efficacy of a DC vaccine in a murine breast cancer model, an effect that could be due to reduction of PD-L1 by blocking HIF-1α (25). The gene discussed is HIF1A; the disease is breast carcinoma.